SLDB icon

Solid Biosciences

67 hedge funds and large institutions have $39.5M invested in Solid Biosciences in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 23 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

less first-time investments, than exits

New positions opened: | Existing positions closed:

52% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 23

52% less capital invested

Capital invested by funds: $83.2M → $39.5M (-$43.6M)

Holders
67
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$65K
Puts
$12K
Net Calls
Net Calls Change

Top Buyers

1 +$1.79M
2 +$712K
3 +$417K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$293K
5
E
Ergoteles
New York
+$158K

Top Sellers

1 -$3.08M
2 -$1.82M
3 -$1.33M
4
IC
Ikarian Capital
Texas
-$625K
5
State Street
State Street
Massachusetts
-$453K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$8.26M
2
$7.61M
3
$4.88M
4
$3.29M
5
$3.12M
6
$1.85M
7
$1.79M
8
$1.77M
9
$1.59M
10
$904K
11
$873K
12
$712K
13
$424K
14
$386K
15
$236K
16
$209K
17
$182K
18
$158K
19
$139K
20
$137K
21
$129K
22
$97K
23
$97K
24
$70K
25
$55K